Endothelial function in infarct-related arteries: Does the type of reperfusion therapy matter?;Función endotelial en la arteria que causa el infarto: ¿es importante la modalidad del tratamiento de reperfusión?

Revista Espanola de Cardiologia

Volumn 61, Issue 8, 2008, Pages 797-799

  Barrabés, José A ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOCARDIOGRAPHY; ATHEROSCLEROSIS; CELL PROLIFERATION; EDITORIAL; ENDOTHELIAL DYSFUNCTION; HEART INFARCTION; HEART MUSCLE REPERFUSION; HUMAN; HYPERTENSION; RISK FACTOR; STENT;

EID: 49449091844     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1157/13124989     Document Type: Editorial

References (20)

1. Kuvin JT, Karas RH. Clinical utility of endothelial function testing: ready for prime time? Circulation. 2003;107:3243-7.
2. Halcox J, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation. 2002;106:653-8.
3. Agulló L, Garcia-Dorado D, Escalona N, Inserte J, Ruiz-Meana M, Barrabés JA, et al. Hypoxia and acidosis impair cGMP synthesis in microvascular coronary endothelial cells. Am J Physiol Heart Circ Physiol. 2002;283:H917-25.
4. Tsao PS, Aoki N, Lefer DJ, Johnson G 3rd, Lefer AM. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation. 1990;82:1402-12.
5. Barrabés JA, Garcia-Dorado D, Mirabet M, Inserte J, Agulló L, Soriano B, et al. Antagonism of selectin function attenuates microvascular platelet deposition and platelet-mediated myocardial injury after transient ischemia. J Am Coll Cardiol. 2005;45:293-9.
6. Barrabés JA, Mirabet M, Agulló L, Figueras J, Pizcueta P, Garcia-Dorado D. Platelet deposition in remote cardiac regions after coronary occlusion. Eur J Clin Invest. 2007;37:939-46.
7. Uren NG, Crake T, Lefroy DC, De Silva R, Davies GJ, Maseri A. Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction. N Engl J Med. 1994;331:222-7.
8. Iràculis E, Cequier A, Gómez-Hospital JA, Sabaté M, Mauri J, Fernández-Nofrerias E, et al. Early dysfunction and long-term improvement in endothelium-dependent vasodilation in the infarct-related artery after thrombolysis. J Am Coll Cardiol. 2002;40:257-65.
9. Obata JE, Kitta Y, Takano H, Kodama Y, Nakamura T, Mende A, et al. Sirolimus-eluting stent implantation aggravates endothelial vasomotor dysfunction in the infarct-related coronary artery in patients with acute myocardial infarction. J Am Coll Cardiol. 2007;50:1305-9.
10. González-Costello J, Iràculis E, Gómez-Hospital JA, Maristany J, Jara F, Espulgas E, et al. Menor vasoconstricción precoz dependiente del endotelio en la arteria que causa el infarto tras angioplastia primaria en comparación con trombolisis después de un infarto agudo de miocardio. Rev Esp Cardiol. 2008;61:817-24.
11. Kashyap VS, Reil TD, Moore WS, Hoang TX, Gelabert HA, Byrns RE, et al. Acute arterial thrombosis causes endothelial dysfunction: a new paradigm for thrombolytic therapy. J Vasc Surg. 2001;34:323-9.
12. Barrabés JA, Garcia-Dorado D, Oliveras J, González MA, Ruiz-Meana M, Solares J, et al. Intimal injury in a transiently occluded coronary artery increases myocardial necrosis: effect of aspirin. Pflügers Arch. 1996;432:663-70.
13. Loukogeorgakis SP, Panagiotidou AT, Yellon DM, Deanfield JE, MacAllister RJ. Postconditioning protects against endothelial ischemia-reperfusion injury in the human forearm. Circulation. 2006;113:1015-9.
14. Heitzer T, Ollmann I, Köke K, Meinertz T, Munzel T. Platelet glycoprotein IIb/IIIa receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease. Circulation. 2003;108:536-41.
15. Warnholtz A, Ostad MA, Velich N, Trautmann C, Schinzel R, Walter U, et al. A single loading dose of clopidogrel causes dose-dependent improvement of endothelial dysfunction in patients with stable coronary artery disease: results of a double-blind, randomized study. Atherosclerosis. 2008;196:689-95.
16. Betriu A. Importancia del factor tiempo en la elección de la terapia de reperfusión. Rev Esp Cardiol. 2007;60:791-3.
17. De la Torre-Hernández JM, Alfonso F, Hernández F, Elizaga J, Sanmartin M, Pinar E, et al. Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos). J Am Coll Cardiol. 2008;51:986-90.
18. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med. 2003;349:523-34.
19. Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001;345:1583-92.
20. Schulman SP, Becker LC, Kass DA, Champion HC, Terrin ML, Forman S, et al. L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. JAMA. 2006;295:58-64.